Cardiovascular risk factors in non‐alcoholic fatty liver disease
Hannes Hagström, Patrik Nasr, Mattias Ekstedt et al. · Liver International · 2018
BACKGROUND & AIMS: Patients with non-alcoholic fatty liver disease (NAFLD) are at an increased risk for cardiovascular disease (CVD). It is unclear whether histological variables may help predict CVD risk. We evaluated histology and traditional CV risk factors as predictors of CVD outcomes in a large NAFLD cohort. METHODS: We included 603 biopsy-proven NAFLD patients free of baseline CVD and matched these (1:10, by age, sex and municipality) to 6269 population controls. All individuals were cross-linked to national registries to ascertain incident CVD events, defined as acute ischaemic heart disease or stroke. The presence of CV risk factors and liver histology were available in NAFLD patients only. Cox regression models were used to estimate hazard ratios (HR) for incident CVD. RESULTS: During a mean follow-up of 18.6 years, 168 (28%) of NAFLD patients and 1325 (21%) of controls experienced a CVD event (HR 1.54, 95%CI 1.30-1.83). Within the NAFLD cohort, age, male sex, type 2 diabetes, smoking and triglycerides were associated with risk of CVD. Taking these CV risk factors into account, no histological parameter, including presence of NASH and fibrosis stage, were associated with incident CVD. CONCLUSIONS: Patients with NAFLD are at an increased risk for CVD compared to matched controls, but histological parameters do not seem to independently predict this risk.
Cited by 109 works. doi:10.1111/liv.13973
Authors
- Hannes Hagström
- Patrik Nasr
- Mattias Ekstedt
- Ulf Hammar
- Per I Stal
- Johan Askling
- Rolf W. Hultcrantz
- Stergios Kechagias
References
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
- External review and validation of the Swedish national inpatient register
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis